Decoding Your Pathology Report

When a doctor removes an eye freckle for testing, a pathologist examines the tissue under a microscope to confirm its identity. This process, called an excisional biopsy, involves removing the entire lesion using a “no-touch” technique to keep the cells intact for an accurate diagnosis ^[1]. The resulting pathology report provides a detailed “fingerprint” of the spot, describing its architecture, cellular makeup, and biological markers.

Important Note: Pathology reports are complex medical documents. You should always interpret your pathology report directly with your treating ophthalmologist or ocular pathologist.

The Three Main Subtypes

Pathologists classify conjunctival nevi based on where the melanocytes (pigment cells) are sitting within the layers of the eye’s surface ^[2]. You will likely see one of these terms on your report:

• Compound Nevus: This is the most common type, making up about 60% of cases ^[3]. The cells are found both in the top layer (epithelium) and the layer just beneath it (stroma) ^[2].
• Subepithelial Nevus: The cells have moved entirely below the surface layer. These are often seen in slightly older adults ^[3].
• Junctional Nevus: The cells are only found at the “junction” where the top and bottom layers meet. This is the least common subtype and is often found in children or young adults ^[3][2].

Reading the “Stains”: PRAME and Others (Optional Tests)

Pathologists sometimes use specialized “dyes” called immunohistochemical stains to see specific proteins within the cells. These stains help them distinguish a benign freckle from more serious conditions like melanoma, though they are not routinely required for every simple nevus.

One of the most important modern markers is PRAME (Preferentially Expressed Antigen in Melanoma) ^[4].

• Negative Result (Score 0): This is the most common result for a benign nevus ^[5]. Most nevi do not show this protein, which is a reassuring sign ^[4].
• Diffuse Positive (Score 4): If many of the cells’ nuclei “light up” for PRAME, it is a signal that the lesion might be malignant ^[4]. However, PRAME is an adjunct tool that depends on the lab’s specific assay; diffuse staining may support melanoma, but a negative result does not completely exclude it, and focal staining can occur in benign lesions ^[6].

Your doctor will also look for other markers like Melan-A, S100, or HMB-45, which simply confirm that the cells are indeed pigment cells ^[1].

Biological Signatures: BRAF and NRAS (Optional Tests)

Your pathology report may also mention genetic mutations like BRAF or NRAS. While “mutation” is a scary word often linked to cancer, in the context of an eye freckle, these are often just the “biological signature” of the growth ^[7].

• BRAF V600E: This is a very common finding in benign conjunctival nevi ^[8]. Its presence helps the cells grow into a freckle, but it does not mean the lesion is cancer ^[7].
• NRAS: This is another common “driver” mutation found in nevi, often associated with spots that have been present since childhood ^[7].
  Note that these molecular findings alone do not establish benignity and are interpreted alongside the physical appearance of the cells.

Reassuring Signs on Your Report

When you read your report, several key features point toward a benign (harmless) diagnosis, though none are absolute guarantees:

• Intralesional Cysts: The presence of these tiny, clear bubbles is one of the strongest indicators of a benign nevus ^[9].
• Symmetry and Circumscription: A benign nevus usually has clean, well-defined edges ^[10].
• Low Ki-67: This is a “proliferation marker” that shows how fast cells are dividing. In a benign nevus, this number is typically very low, meaning the spot is not growing aggressively, though no universal cutoff exists ^[1].
• Clear Margins: This means no tumor cells were seen at the examined edge of the removed tissue. It suggests complete removal, though it does not guarantee recurrence is impossible ^[11].

If your report contains words like “atypia” (abnormal looking cells), “mitoses” (actively dividing cells), or “pagetoid spread” (cells migrating upward into the surface layers), your doctor will discuss these closely with you. These terms can indicate a more serious melanocytic lesion and should prompt a direct discussion of the diagnosis and treatment plan with an ocular oncologist ^[12][13].